Novel murine cell lines with defined mutations model different histological subtypes of epithelial ovarian cancer
Open Access
- 11 July 2025
- journal article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 18 (7)
Abstract
Preclinical modeling of epithelial ovarian cancer in immune competent mice progressing to orthotopic, spontaneous tumors is challenging, requiring multiple genetic modifications in the host. Transplantable models using cell lines are easier to implement, given that they reproduce the key disease characteristics. To create new in vivo ovarian tumor models, we have generated a total of 28 murine ovarian cancer cell lines with distinct genetic traits such as deletion of Trp53, activation of KrasG12D, deletion of Pten or KrasG12D/Pten−/- combination. Two distinct Trp53 null cell lines recapitulate high grade serous histology when orthotopically injected in immune competent, syngeneic hosts. Cells with Pten deletion trigger high grade endometrioid tumors, and cells with dual KrasG12D activation and Pten deletion model carcinosarcoma. The cells express different tumor antigens, secrete varying levels of cytokines and chemokines, and trigger tumors with diverse inflammation profiles and various intratumoral T and B lymphocyte infiltration patterns. RNAseq data from 16 cell lines reveal the gene expression profile across distinct models with different histotypes. This versatile collection of murine cell lines supports translationally relevant studies in ovarian cancer.Keywords
Funding Information
- National Cancer Institute (R01CA163462, R01CA238315, P01CA234212)
This publication has 93 references indexed in Scilit:
- Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tractNature Medicine, 2005
- Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancerNature Medicine, 2004
- Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium.2003
- Faculty Opinions recommendation of Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.2003
- Generation of a Syngeneic Mouse Model to Study the Effects of Vascular Endothelial Growth Factor in Ovarian CarcinomaThe American Journal of Pathology, 2002
- Osteopontin as a Potential Diagnostic Biomarker for Ovarian CancerJAMA, 2002
- Induction of ovarian cancer by defined multiple genetic changes in a mouse model systemCancer Cell, 2002
- Development of a syngeneic mouse model for events related to ovarian cancerCarcinogenesis, 2000
- Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancerBritish Journal of Cancer, 1995
- Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice.1992